Details for New Drug Application (NDA): 202598
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 202598
Tradename: | SILDENAFIL CITRATE |
Applicant: | Chartwell Rx |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202598
Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Medical Subject Heading (MeSH) Categories for 202598
Suppliers and Packaging for NDA: 202598
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 202598 | ANDA | Chartwell RX, LLC | 62135-372 | 62135-372-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-372-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Nov 6, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription